Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites

References

• Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004;58:265–78
   PubMed Web of Science ®Google Scholar
• Noyes A, Whitney W. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–4
   Google Scholar
• Bruno JA, Doty BD, Gustow E, et al. Method of grinding pharmaceutical substances. 1996; US Patent 5518187
   Google Scholar
• Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 2008;364:64–75
   PubMed Web of Science ®Google Scholar
• Gupta RB, Kompella U. Nanoparticle technology for drug delivery. New York: Taylor and Francis; 2006
   Google Scholar
• Kim CJ. Surface chemistry and colloids, advanced pharmaceutics: physicochemical principles. CRC Press; 2004
   Google Scholar
• Bilgili E, Afolabi A. A combined microhydrodynamics–polymer adsorption analysis for elucidation of the roles of stabilizers in wet stirred media milling. Int J Pharm 2012;439:193–206
   PubMed Web of Science ®Google Scholar
• Ryde N, Ruddy S. Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate. 2002; US Patent 6375986
   Google Scholar
• Lee J. Drug nano and microparticles processed into solid dosage forms: physical properties. J Pharm Sci 2003;92:2057–68
   PubMed Web of Science ®Google Scholar
• Tewa-Tagne P, Briançon S, Fessi H. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation. Eur J Pharm Sci 2007;30:124–35
   PubMed Web of Science ®Google Scholar
• Basa S, Muniyappan T, Karatgi P, et al. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Dev Ind Pharm 2008;34:1209–18
   PubMed Web of Science ®Google Scholar
• Chaubal C, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res 2008;25:2302–8
   PubMed Web of Science ®Google Scholar
• Kim S, Lee J. Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions. Int J Pharm 2010;397:218–24
   PubMed Web of Science ®Google Scholar
• Bhakay A, Bilgili E, Dave R. Recovery of BCS Class II drugs during aqueous redispersion of core–shell type nanocomposite particles produced via fluidized bed coating. Powder Technol 2013;236:221–34
   Web of Science ®Google Scholar
• Bhakay A, Azad M, Vizzotti E, et al. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants. Drug Dev Ind Pharm 2014;40:1509--22
   Google Scholar
• Bhakay A, Azad M, Bilgili E, Dave R. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs. Int J Pharm Sci 2014;461:367–79
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Delivery Rev 2007;59:631–44
   PubMed Web of Science ®Google Scholar
• Bilgili E, Bhakay A, Azad M, Dave R. Systems and methods for superdisintegrant-based composite particles for dispersion and dissolution of agents. 2013; US Patent Application, US 2013/0295190 A1
   Google Scholar
• Kho K, Hadinoto K. Effects of excipient formulation on the morphology and aqueous re-dispersibility of dry-powder silica nano-aggregates. Colloid Surf A 2010;359:71–81
   Web of Science ®Google Scholar
• Hu J, Ng WK, Dong Y, et al. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm 2011;404:198–204
   PubMed Web of Science ®Google Scholar
• Mou D, Chen H, Wan J, et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm 2011;413:237–44
   PubMed Web of Science ®Google Scholar
• Niwa T, Miura S, Danjo K. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs. Pharm Res 2011;28:2339–49
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. Miconazole nanosuspensions: influence of formulation variables on particle size reduction and physical stability. Int J Pharm 2010;396:210–8
   PubMed Web of Science ®Google Scholar
• Knieke C, Azad M, Dave R, Bilgili E. A study of the physical stability of wet media-milled fenofibrate suspensions using dynamic equilibrium curves. Chem Eng Res Des 2013;91:1245–58
   Web of Science ®Google Scholar
• Florence, AT. Drug solubilization in surfactant systems. In: Yalkowsky SH, ed. Techniques of solubilization of drugs. New York: Marcel Dekker; 1981
   Google Scholar
• Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm 2011;406:145–52
   PubMed Web of Science ®Google Scholar
• Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 2011;409:260–8
   PubMed Web of Science ®Google Scholar
• Gupta S, Kesarla R, Omri A. Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems. ISRN Pharm 2013. doi:10.1155/2013/848043. Article ID 848043
   Google Scholar
• Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 1995;125:91–7
   Google Scholar
• Suzuki M, Machida M, Adachi K, et al. Histopathological study of the effects of a single intratracheal instillation of surface active agents on lung in rats. J Toxicol Sci 2000;25:49–55
   PubMedGoogle Scholar
• Wong J, Brugger A, Khare A, et al. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Delivery Rev 2008;60:939–54
   PubMed Web of Science ®Google Scholar
• Lebhardt T, Roesler S, Uusitalo H, Kissel T. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation. Eur J Pharm Biopharm 2011;78:90–6
   PubMed Web of Science ®Google Scholar
• Augsburger L, Brzeczko A, Shah U, Hahm H. Superdisintegrants: characterization and function. In: Swarbrick J, ed. Encyclopedia of pharmaceutical technology. New York: Informa Healthcare USA Inc.; 2007:3553–67
   Google Scholar
• Omidian H, Park K. Swelling agents and devices in oral drug delivery. J Drug Delivery Sci Technol 2008;18:83–93
   Web of Science ®Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol 1996;20:64–74
   Google Scholar
• Azad M, Afolabi A, Patel N, et al. Production of colloidal suspensions of superdisintegrants via wet stirred media milling. Particuology 2014;14:76–82
   Web of Science ®Google Scholar
• US FDA. Guidance for industry: dissolution testing of immediate-release solid oral dosage forms. US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Aug 1997. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070237.pdf. [last accessed 1 Aug 2014]
   Google Scholar
• Qureshi S, Shabnam J. Cause of high variability in drug dissolution testing and its impact on setting tolerances. Eur J Pharm Sci 2001;12:271–6
   PubMed Web of Science ®Google Scholar
• Rasenack N, Hartenhauer H, Muller B. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm 2003;254:137–45
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Vermant J, Martens J, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci 2009;98:2091–103
   PubMed Web of Science ®Google Scholar
• Winnik FM, Winnik MA. The interaction of sodium dodecylsulfate with (hydroxypropyl) cellulose. Polym J 1990;22:482–8
   Web of Science ®Google Scholar
• Petrović LB, Sovilj VJ, Katona, JM, Milanovic JL. Influence of polymer–surfactant interactions on o/w emulsion properties and microcapsule formation. J Colloid Interface Sci 2010;342:333–9
   PubMed Web of Science ®Google Scholar
• Quadir A, Kolter K. A comparative study of current superdisintegrants. Pharm Technol 2006;30:s38–42
   Google Scholar
• Brazel CS, Rosen SL. Fundamental principles of polymeric materials. New York: Wiley-Interscience; 1993
   Google Scholar
• Sombatsompop N, Christodoulo K. Penetration of aromatic hydrocar-bons into natural rubber. Polym Polym Compos 1997;5:377–86
   Web of Science ®Google Scholar
• Vehring R, Foss W, Lechuga-Ballesteros D. Particle formation in spray drying. J Aerosol Sci 2007;38:728–46
   Web of Science ®Google Scholar
• Maa Y, Nguyen P, Andya J, et al. Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders. Pharm Res 1998;15:768–75
   PubMed Web of Science ®Google Scholar
• Monteiro A, Afolabi A, Bilgili E. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect. Drug Dev Ind Pharm 2013;39:266–83
   PubMed Web of Science ®Google Scholar
• Van Eerdenbrugh B, Froyen L, Humbeeck J, et al. Alternative matrix formers for nanosuspension solidification: dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. Eur J Pharm Sci 2008;35:344–53
   PubMed Web of Science ®Google Scholar